The next frontier in weight-loss drugs: one-time gene therapy
bookofjoe Saturday, February 07, 2026
Summary
The article discusses a new gene therapy treatment developed by Fractyl Laboratories that targets the GLP-1 gene, which plays a role in regulating blood sugar levels. The treatment aims to address the underlying causes of type 2 diabetes and potentially eliminate the need for daily medication.
2
1
Summary
washingtonpost.com